Evolution of surgical modalities and distribution of pathological types in ovarian cancer patients over five years

Yi Jin

doi:10.47297/wspbdsWSP2752-630530.20250501

PDF
Export
Share
Collection
Album

Evolution of surgical modalities and distribution of pathological types in ovarian cancer patients over five years

Volume 5, Issue 1

Views: 0 Downloads: 0

Evolution of surgical modalities and distribution of pathological types in ovarian cancer patients over five years
Evolution of surgical modalities and distribution of pathological types in ovarian cancer patients over five years
Nanjing Maternal and Child Health Care Hospital, Nanjing 210004, Jiangsu, China
Vol. 5, Issue 1, Pages: 135-138(2025)
Published：19 March 2025
DOI：10.47297/wspbdsWSP2752-630530.20250501
Accepted：

Scan QR Code

Yi Jin.Evolution of surgical modalities and distribution of pathological types in ovarian cancer patients over five years[J].Biomedical Data Science,2025,05(01):135-138.
DOI：

Yi Jin.Evolution of surgical modalities and distribution of pathological types in ovarian cancer patients over five years[J].Biomedical Data Science,2025,05(01):135-138. DOI： 10.47297/wspbdsWSP2752-630530.20250501.

摘要

Abstract

In many female groups

ovarian cancer is one of the common malignant tumors of female reproductive organs

the incidence is 5% of all malignant tumors in women. According to clinical statistics

the survival rate of ovarian cancer patients within 5 years is only 25% to 39%. At present

with the continuous development of clinical medical technology

the treatment and surgical methods of clinical diagnosis of ovarian cancer are also changing. Based on the analysis of current clinical research results

it can be seen that in the current surgical treatment of ovarian cancer patients

the surgical method has gradually changed from the traditional comprehensive staging surgery to tumor cell reduction surgery

and the form of surgery has gradually changed from the initial open surgery to minimally invasive surgery. In the population of ovarian cancer patients

the main pathological type is epithelial ovarian cancer. In this study

based on the research and review of existing medical literature

the evolution of surgical methods and the distribution of pathological types of ovarian cancer patients in the past five years were reviewed

hoping that this study could provide some practical experience sharing and reference for the clinical treatment of ovarian cancer patients.

关键词

Keywords

references

Cui Xaxia , He Yijiao , Wang Yiqin , et al . Clinical analysis of 8 cases of early endometrial carcinoma complicated with ovarian malignancy in nursing treatment [J ] . Chinese Journal of Obstetrics and Gynecology , 2024 , 25 ( 6 ): 521 - 525 . (in Chinese) DOI: 10.13390/j.issn.1672-1861.2024.06.011 http://dx.doi.org/10.13390/j.issn.1672-1861.2024.06.011 .

Yang Jie , Yang Jiaxin , Wang Jinhui , et al . Malignant ovarian germ cell tumors [J ] . China expert consensus of diagnosis and treatment of clinical progress in modern obstetrics and gynecology , 2024 , 33 ( 8 ) : 561 - 568 . The DOI: 10.13283 / j.carol carroll nki XDFCKJZ. 2024.08.001 http://dx.doi.org/10.13283/j.carolcarrollnkiXDFCKJZ.2024.08.001 .

Chen Wutao , Jin Mingzhu , Di Wen . The whole disease cycle management of ovarian cancer [J ] . Journal of medicine , Shanghai 2023 , 46 ( 11 ) : 720 - 724 . The DOI: 10.19842 / j.carol carroll nki. Issn 0253-9934.2023.11.003 http://dx.doi.org/10.19842/j.carolcarrollnki.Issn0253-9934.2023.11.003 .

Wang J . Surgical perspective on the key links of ovarian cancer tumor cell reduction [J ] . Shanghai medicine , 2023 , 46 ( 11 ) : 730 - 734 . The DOI: 10.19842 / j.carol carroll nki. Issn 0253-9934.2023.11.005 http://dx.doi.org/10.19842/j.carolcarrollnki.Issn0253-9934.2023.11.005 .

Bian Jing . Analysis of the clinical value of lymph node resection in the treatment of advanced epithelial ovarian cancer [D ] . Zhengzhou University , 2019 .

Ren Lu . Clinical effect and survival of patients with advanced ovarian cancer treated with different surgical protocols [J ] . Journal of Community Medicine , 2015 , 13 ( 13 ): 60 - 62 .

[ 7] Experience in the clinical treatment of epithelial ovarian cancer [J ] . Chinese Journal of Modern Pharmaceutical Application , 2013 , 7 ( 4 ): 48 . (in Chinese) DOI: 10.14164/j.cnki.cn11-5581/r.2013.04.090 http://dx.doi.org/10.14164/j.cnki.cn11-5581/r.2013.04.090 .

Xiao Xiulan . Curative effect of neoadjuvant chemotherapy combined with operation in the treatment of advanced ovarian cancer: a report of 28 cases [J ] . Current Medicine , 2013 , 19 ( 1 ): 81 - 82 .

[ 9] Recent and long-term efficacy of neoadjuvant chemotherapy combined with surgery for advanced ovarian cancer [J ] . Modern Preventive Medicine , 2011 , 38 ( 14 ): 2724 - 2725+2730 . (in Chinese)

Gong Mei , Jin Xin , Fang Yong , et al . Efficacy of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer [J ] . China Maternal and Child Health Care , 2011 , 26 ( 18 ): 2828 - 2830 . (in Chinese)

Li Hua , Li Fang , Song Aiqin . Long-term efficacy observation of operation plus VPC for ovarian cancer [J ] . Qilu Oncology , 1998 ( 4 ): 44 - 45 .

Alert me when the article has been cited

Submit

Study on the Anti-Tumor Effect of CSF-1R Inhibitor Combined with Chemotherapy in the Treatment of Ovarian Cancer

Related Author

FeI Song China Medical University

Related Institution

China Medical University

⁰